Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02173236 · ClinicalTrials.gov registry record · NA

The Effect of Platform Switching on Single Implants in the Esthetic Zone, Following Flapless Surgery and Early-Loading Protocols

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT02173236: Completed NA study, sponsored by University of Michigan.

NCT02173236 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02173236, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The impact of platform switching with flapless surgery on early-loaded single-tooth implants on esthetic outcomes.

Primary Outcome

(Silness and Loe 1964). 0 represented the absence of plaque. 1 was the presence of plaque at gingival margin. 2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed

Interventions

  • OTHER platform-switched implants
  • OTHER platform-matched implant

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2011-06
Est. Completion 2014-03
Phase NA
University of Michigan

1,327 total trials

What the finished NCT02173236 record still lists

NCT02173236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which platform-switched implants is the first listed.

NCT02173236 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02173236 about?

NCT02173236 is a clinical study titled "The Effect of Platform Switching on Single Implants in the Esthetic Zone, Following Flapless Surgery and Early-Loading Protocols". The impact of platform switching with flapless surgery on early-loaded single-tooth implants on esthetic outcomes.

What is the current status of trial NCT02173236?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2011-06. Estimated completion is 2014-03.

What interventions are being tested in trial NCT02173236?

The interventions under investigation include: platform-switched implants (OTHER), platform-matched implant (OTHER).

Who is sponsoring clinical trial NCT02173236?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02173236's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02173236, the US trial registry maintained by the National Library of Medicine. NCT02173236 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.